Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence

BJU International
Claus G RoehrbornZhonghong Guan

Abstract

A group of authors from the USA evaluated the efficacy and tolerability of tolterodine extended-release on objective and subjective endpoints in men with an overactive bladder. They found that it significantly reduced incontinent episodes and improved patient perception of treatment benefit in men with an overactive bladder To evaluate the efficacy and tolerability of tolterodine extended-release (ER) on objective and subjective endpoints in men with overactive bladder (OAB) and urgency urinary incontinence (UI). PATIENTS AND METHODS This was a post hoc analysis of data collected from men with OAB enrolled in a 12-week, double-blind, placebo-controlled trial of tolterodine ER (4 mg once daily; tolterodine ER registration trial) and included men with urinary frequency (> or =8 micturitions/24 h) and urgency UI (> or =5 episodes/week). UI episodes were assessed using 7-day bladder diaries. Patient perception of treatment benefit was evaluated after 12 weeks. Adverse events (AEs) were recorded throughout the study. In all, 163 men with OAB (placebo, 86; tolterodine ER, 77; mean age 65 years) were evaluated. Baseline demographics and clinical characteristics were similar for the two treatment groups. Compared with placebo, tolterod...Continue Reading

References

Dec 1, 1987·British Journal of Urology·S C HarrisonP T Doyle
Mar 15, 2001·Urology·P Van KerrebroeckUNKNOWN Tolterodine Study Group
Apr 27, 2001·Mayo Clinic Proceedings·R A AppellUNKNOWN Overactive Bladder: Judging Effective Control and Treatment Study Group
May 26, 2001·World Journal of Urology·R A AppellA Wein
Feb 1, 2003·Urology·Paul AbramsUNKNOWN Standardisation Sub-Committee of the International Continence Society
Jun 18, 2003·World Journal of Urology·W F StewartA J Wein
Nov 25, 2003·BJU International·P BoyleUNKNOWN UrEpik Study Group
Sep 29, 2004·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Karin S CoyneTimothy L Hunt

❮ Previous
Next ❯

Citations

Aug 26, 2009·World Journal of Urology·Osamu YamaguchiMasanori Nomiya
Apr 7, 2007·Nature Clinical Practice. Urology·Gary E Lemack
Jan 8, 2011·International Journal of Clinical Practice·S A KaplanZ Guan
Oct 1, 2009·Therapeutic Advances in Urology·Roger R Dmochowski, Alex Gomelsky
Mar 4, 2014·Der Urologe. Ausg. A·R Kirschner-Hermanns, R Anding
Apr 20, 2014·Indian Journal of Urology : IJU : Journal of the Urological Society of India·Nadir I OsmanChristopher R Chapple
Jul 1, 2014·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·S LebdaiA Descazeaud
Dec 4, 2009·Expert Opinion on Pharmacotherapy·David R Staskin, Dudley Robinson
Dec 15, 2015·International Journal of Surgery·Haitham AbdelmotelebMarcus J Drake
Jan 23, 2010·European Urology·Roger Dmochowski
Aug 18, 2009·The Journal of Urology·Elisa Martín-MerinoClaus G Roehrborn
Oct 9, 2009·International Journal of Urology : Official Journal of the Japanese Urological Association·Yukio HommaUNKNOWN Japanese Society of Neurogenic Bladder
Feb 29, 2008·International Journal of Urology : Official Journal of the Japanese Urological Association·Debra A Schwinn, Claus G Roehrborn
Nov 5, 2011·International Journal of Urology : Official Journal of the Japanese Urological Association·Yukio HommaUNKNOWN Japanese Urological Association
Feb 4, 2010·Neurourology and Urodynamics·Anastasios Athanasopoulos
Jul 8, 2015·Current Urology Reports·Mauro GacciSergio Serni
Apr 22, 2008·Expert Opinion on Pharmacotherapy·Stefano SalvatorePierfrancesco Bolis
May 9, 2014·Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society·Chunlan JinRan Pang
Nov 16, 2013·Current Opinion in Urology·João SilvaFrancisco Cruz
Aug 13, 2011·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Michael G Oefelein
Aug 9, 2017·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·Lars HenningsohnJudith L Jacobsen
Jan 17, 2017·Current Urology Reports·Matthew C MossAlex Gomelsky
Jul 10, 2019·Urologia·Marta RossaneseVincenzo Ficarra

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.